Wearable stroke rehabilitation device gives patients the upper hand

Nine Patients Received a Personalized Kidney Cancer Vaccine. None Had a Recurrence.

New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Weekly cisplatin shows similar burden of acute treatment side effects as every 3-week schedule for patients with p16-negative head and neck cancer on NRG oncology trial